DrugCard is an advanced AI tool specifically designed to facilitate local literature screening within the pharmaceutical industry. This innovative tool ensures that drug safety routines are streamlined and fully compliant with regulatory demands. It offers a high degree of transparency and traceability, making it a reliable partner for pharmaceutical companies, Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers. DrugCard stands out for its ability to continuously screen the latest local literature across global markets, providing a comprehensive, efficient, and cost-effective solution for the industry.
Problem: Pharmacovigilance teams manually review hundreds of local medical journals, which is time-consuming and prone to human error.
Solution: DrugCard automates the screening of over 1,817 local journals across 100+ languages, identifying relevant safety information instantly.
Example: A pharmaceutical company uses DrugCard to monitor regional medical publications in 104 countries to identify any mentions of adverse reactions associated with their products.
Problem: Contract Research Organizations (CROs) often struggle to maintain high-quality screening standards while managing multiple client projects.
Solution: The platform provides a centralized, scalable solution that allows CROs to manage more pharmacovigilance projects with higher accuracy and 60% time savings.
Example: A CRO implements DrugCard to automate the cover-to-cover reading of journals for five different clients, freeing up staff for high-priority signal detection tasks.
Problem: Marketing Authorization Holders (MAHs) face increasing pressure from regulators to provide transparent and traceable documentation of their drug safety routines.
Solution: DrugCard offers a high degree of transparency and traceability, ensuring that all screening activities are logged and compliant with GVP regulations.
Example: During a regulatory audit, an MAH quickly generates comprehensive reports from DrugCard to prove their literature monitoring process is holistic and compliant.
Target audience: Best for: Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and Pharmacovigilance Freelancers
Pricing: Unknown · Categories: Healthcare
Tags: editing, healthcare, legal assistant, life assistant, music
DrugCard is a specialized artificial intelligence tool designed for automated local literature screening within pharmacovigilance. It enables pharmaceutical teams to monitor regional scientific publications for safety alerts, adverse events, and drug reactions. By organizing global data feeds into a centralized repository, DrugCard assists drug safety specialists in maintaining continuous surveillance across diverse regional markets and medical publishing sources without requiring manual reading.
DrugCard automates the continuous screening of over 1,800 medical journals published across 104 countries in more than 100 languages. It scans texts to detect mentions of adverse events and safety signals relevant to monitored products. Key capabilities include an integrated adverse event database, real-time regulatory intelligence tracking, traceable audit trails for compliance inspections, and eCTDlight electronic documentation management for standardized record keeping.
DrugCard is designed for pharmacovigilance professionals, including Contract Research Organizations, Marketing Authorization Holders, pharmaceutical companies, and freelance drug safety specialists. Contract Research Organizations use it to handle literature monitoring across multiple client projects, while Marketing Authorization Holders employ it to meet strict local literature review mandates under Good Pharmacovigilance Practices guidelines across different national regulatory bodies.
DrugCard supports regulatory compliance by recording all literature screening actions in transparent, traceable audit trails. The platform logs when publications were reviewed, what keywords were screened, and any safety findings discovered. When regulatory agencies conduct audits or inspections, teams can export detailed monitoring reports to prove systematic adherence to mandatory local literature surveillance and pharmacovigilance obligations.